Integrated Diagnostics (LON:IDHC) Trading Down 14.5% – Here’s Why

Integrated Diagnostics Holdings plc (LON:IDHC) shares traded down 14.5% during mid-day trading on Friday . The company traded as low as GBX 0.52 and last traded at GBX 0.52. 229,814 shares changed hands during trading, an increase of 15% from the average daily volume of 199,824 shares. The stock had previously closed at GBX 0.61.

Integrated Diagnostics Price Performance

The firm has a fifty day moving average of GBX 0.54 and a two-hundred day moving average of GBX 0.58. The stock has a market capitalization of £3.02 million, a P/E ratio of 0.00, a P/E/G ratio of 7.65 and a beta of 0.38.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.